The Impact of Transcriptomics on the Fight against Tuberculosis: Focus on Biomarkers, BCG Vaccination, and Immunotherapy
In 1882 Robert Koch identified Mycobacterium tuberculosis as the causative agent of tuberculosis (TB), a disease as ancient as humanity. Although there has been more than 125 years of scientific effort aimed at understanding the disease, serious problems in TB persist that contribute to the estimate...
Saved in:
Main Authors: | Carlos Rodrigo Zárate-Bladés, Celio Lopes Silva, Geraldo A. Passos |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2011/192630 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bacillus Calmette-Guerin (BCG) infections following intravesical BCG immunotherapy: a systematic review protocol
by: Roberta Monardo, et al.
Published: (2025-01-01) -
Is the BCG Vaccine Safe for Undernourished Individuals?
by: Larissa Lumi Watanabe Ishikawa, et al.
Published: (2012-01-01) -
Comparative performance of tuberculin and defined-antigen cocktails for detecting bovine tuberculosis in BCG-vaccinated cattle in natural settings
by: Abebe Fromsa, et al.
Published: (2025-02-01) -
Vaccines in the fight against antimicrobial resistance – perspectives from South Africa
by: A Brink, et al.
Published: (2024-09-01) -
Advancing the Fight Against Cervical Cancer: The Promise of Therapeutic HPV Vaccines
by: Qian Zheng, et al.
Published: (2025-01-01)